Author

T. E. Nakajima

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Electronic patient-reported outcome monitoring and quality of life during later-line nivolumab therapy for advanced gastric cancer.

BACKGROUND Health-related quality of life (HRQoL) often deteriorates during later-line treatment for advanced gastric cancer. Although nivolumab monotherapy has been an established treatment option in this setting, HRQoL data remain limited. This study aimed to examine associations between symptomatic adverse events (A...

Y. Horie, S. Oyamada, H. Kawakami et al. · International Journal of Cli... · 0 citations

Open access Sep 2026

Autologous Glypican-3-Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102.

Findings support a manageable safety profile for TAK-102 and provide early evidence of biological activity in solid tumors, and are warranted to optimize dosing, improve CAR T-cell persistence, and evaluate efficacy in larger patient cohorts.

Y. Kuboki, T. Koyama, M. Ikeda et al. · Cancer immunology research · 0 citations